PathAI logo

Webinar: Introduction to the AIM-HER2 Breast Cancer Algorithm

PathAI recently launched the AIM-HER2 Breast Cancer (AIM-HER2) algorithm, an AI-powered HER2 scoring algorithm for biopharma research and laboratories. AIM-HER2 delivers automated digital HER2 scoring and is the market's first algorithm to use additive multiple instance learning (aMIL) heatmaps to visualize the slide features driving the algorithm's predicted score.

Join PathAI's Chief Medical Officer, Eric Walk, during our upcoming webinar where he will explore what is possible as a result of our AIM-HER2 algorithm and AISight, our image management system. By the end of the webinar, you will:
  • Have a better understanding of the core elements of the AIM-HER2 algorithm
  • Be better informed to assess the potential utility of digital pathology in standardizing HER2 scoring of immunohistochemistry stains
Watch Webinar